Sort by
Refine Your Search
-
and proposal preparation. Required qualifications: As a formal qualification, you must hold a PhD degree (or equivalent) in computer science, computer engineering, networking, or related fields relevant
-
research frameworks developed at DTU Integrate product data, regulation, and stakeholder needs into tailored solutions Address behavioural, incentive, and digital aspects of take-back design Collaborate
-
paradigm shift in development of Biologics. A critical challenge preventing this is the current limiting volume of high quality and well-characterized in-vitro T cell immunogenicity data. In this project, we
-
to mutual agreement). The position is a full-time position. You can read more about career paths at DTU here . Further information Further information may be obtained from the PI, Emmanouil Vasilomanolakis
-
Confederation of Professional Associations. The allowance will be agreed upon with the relevant union. The period of employment is 1 year. You can read more about career paths at DTU here . Further information
-
extraction) that can be miniaturized and integrated into portable devices. Perform SERS measurements and data analysis of SERS data (e.g., using machine learning). Develop, test and apply new fiber-based SERS
-
design of study, selecting the best data for execution, performing and reporting analyses. This requires that you are able to work independently and have a desire to seek out and test the most suitable
-
agreed upon with the relevant union. The period of employment is 2 years. You can read more about career paths at DTU here . Further information Further information may be obtained from Prof. Paul Pop
-
the relevant union. The period of employment is 2 years, starting from September 2025 or according to mutual agreement. You can read more about career paths at DTU here . Further information Further information
-
oxygen delivery—without relying on human donors. You’ll build on the 3Bs group's extensive data and recent publications to evaluate the biological performance of these nanocarriers in preclinical models